miR-377 also controls the proliferation, apoptosis, migration, and invasion in metastatic prostate cancer cells by targeting FZD4 [61] whereas miR-101 suppresses the WNT5a-induced proliferation of lung fibroblasts by targeting FZD4/6 [62]. Here, FZD4 is linked to prostate carcinoma.